We identified the IL6/JAK2/STAT3/FOXO4 axis as a novel signaling pathway mediating the local ovarian effects of CDD, providing a new perspective that links its anti-inflammatory and insulin-sensitizing actions at the cellular level. Here, IL6 is linked to craniodiaphyseal dysplasia.